Glucotrol peroral hypoglycemic medicine. It is taken at a diabetes mellitus of type 2 (at inefficiency of dietotherapy). It has pancreatic and extra pancreatic effects. Stimulates secretion of insulin by reductions of the threshold of irritation with glucose of beta cells of pancreas, increases sensitivity to insulin and extent of its linkng with target cells, increases insulin release, strengthens influence of insulin on glucose absorption by muscles and liver, brakes lipolysis in fatty tissue.

The oral hypoglycemic agent, derived from sulfonylureas of the II generation. Used in complex therapy with insulin to control the blood glucose levels daily in diabetes of the second type. Has pancreatic and extrapancreatic effects. Stimulates the secretion of insulin by lowering the threshold of pancreas beta cells’ stimulation by glucose, improves insulin sensitivity and the degree of its binding to target cells, increases insulin release, enhances the effect the insulin has on glucose uptake by muscle and liver, inhibits lipolysis in the adipose tissue.